Skip to main content
Watch Insiders
INBX filings

Corporate insider profile

Mark Lappe Filing Activity

Latest reported as Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX).

Purchase filings
3
Reported companies
1
Net open-market value
$4,493,160
Latest transaction
Oct 14, 2026

Affiliated corporations

Reported company relationships

INBXLatest reported

Inhibrx Biosciences, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 14, 2026Inhibrx Biosciences, Inc. (INBX)Chief Executive OfficerOpen Market Purchase10,040$84.56$848,976
Sep 28, 2026Inhibrx Biosciences, Inc. (INBX)Chief Executive OfficerOpen Market Purchase10,000$99.88$998,784
Sep 8, 2026Inhibrx Biosciences, Inc. (INBX)Chief Executive OfficerOpen Market Purchase25,000$105.82$2,645,400